WebDoctor Encyclopedia

Childhood Liver, bile ducts & pancreas

Solid pseudopapillary neoplasm of the pancreas

Solid pseudopapillary neoplasm (SPN) is a rare, slow-growing, low-grade tumour of the pancreas that mainly affects teenage girls and young women. It is often found by chance and is cured by surgery in over 95% of people.

Medically reviewed Last reviewed October 17, 2026

What is a solid pseudopapillary neoplasm of the pancreas?

A solid pseudopapillary neoplasm (SPN) is a rare, slow-growing tumour of the pancreas. It occurs mainly in teenage girls and young women, and it is the most common pancreatic tumour in older children and adolescents.

The pancreas lies behind the stomach. It makes digestive juices and hormones such as insulin.

SPN is classed as a low-grade malignant tumour. This means it can, in a small number of people, grow into nearby tissue or spread to the liver. However, it behaves very differently from the common type of pancreatic cancer, and almost everyone is cured by surgery (Law et al., 2014).

The tumour was first described by the American pathologist Virginia Frantz in 1959, so it is sometimes called a Frantz tumour.

It gets its name from its appearance under the microscope. It contains solid areas and areas where cells fall away from small blood vessels, leaving finger-like structures that look like papillae but are not true papillae, hence “pseudopapillary”.

1. Key facts at a glance

Feature Details
Type of tumour Low-grade malignant epithelial tumour of the pancreas
How common Rare; about 1-3% of pancreatic tumours removed by surgery (Lubezky et al., 2017)
Who is affected About 9 in 10 are female; average age about 28; also children and teenagers
Main site Anywhere in the pancreas, often the body or tail
Key symptoms Often none; abdominal pain, a lump, feeling full
Gene change CTNNB1 (beta-catenin) mutation in almost all tumours
Main treatment Surgical removal
Outlook Excellent; over 95% are cured by surgery

2. Other names

SPN has had several names over the years, which is why older reports can be hard to compare (Papavramidis and Papavramidis, 2005):

Name Notes
Solid pseudopapillary neoplasm Current WHO name
Solid pseudopapillary tumour Common alternative
Frantz tumour After Virginia Frantz
Solid and cystic tumour Older name describing its appearance
Papillary cystic neoplasm Older name
Hamoudi tumour Older name

3. Causes and risk factors

The cause of SPN is not known. Almost all tumours carry a mutation in the CTNNB1 gene, which makes the protein beta-catenin (Abraham et al., 2002). The mutation makes beta-catenin build up in the cell nucleus, where it switches on growth signals.

Factor Notes
Sex Much more common in females; the reason is not clear, and hormones may play a role
Age Mostly teenagers and young adults
Ethnic background Reported more often in Black and East Asian people (National Cancer Institute, 2026)
Inherited conditions No clear inherited cause in most people
Lifestyle Not linked with smoking, alcohol or diet

SPN is not inherited in most cases and cannot be passed to others.

4. How does it look

On scans

Feature Description
Size Often large when found; average about 8-9 cm (Law et al., 2014)
Shape Round and well-defined, with a capsule
Inside A mix of solid areas, fluid-filled spaces and old bleeding
Calcium Sometimes seen at the edge
Effect on nearby structures Usually pushes rather than invades; bile duct blockage is rare
Small tumours May look completely solid and be mistaken for neuroendocrine tumours

CT and MRI are the main scans. MRI is particularly good at showing bleeding inside the tumour, a typical feature. An endoscopic ultrasound, with a camera passed through the mouth into the stomach, can give close-up pictures and take a sample.

To the surgeon

When removed, the tumour is usually a soft, rounded mass with a fibrous capsule. Cut open, it shows tan solid tissue, areas of bleeding and spaces filled with old blood or debris.

Under the microscope

The WHO classification groups SPN with the epithelial tumours of the exocrine pancreas and treats every case as a low-grade malignant tumour (WHO Classification of Tumours Editorial Board, 2019).

Feature Description
Solid areas Sheets of fairly uniform cells around small blood vessels
Pseudopapillae Cells falling away from vessels, leaving finger-like stalks
Clear or foamy cells Sometimes present, with small pink droplets
Stains Nuclear beta-catenin, CD10, progesterone receptor and SOX11 positive; dot-like CD99; E-cadherin lost

Visible signs

Most people with SPN look well. A large tumour may make the upper abdomen look fuller, especially in slim young people, or may be felt as a firm lump.

5. Symptoms

Many SPNs cause no symptoms and are found by chance on a scan done for another reason, such as after an injury or for unrelated abdominal pain. In a large review, almost 4 in 10 were found this way (Law et al., 2014).

Common symptoms

  • Abdominal pain or discomfort, the most common symptom
  • A lump in the upper abdomen
  • Feeling full quickly after eating
  • Nausea or vomiting
  • Back pain

Less common symptoms

Symptom Cause
Sudden severe pain Bleeding into the tumour or rupture, sometimes after an injury
Weight loss Large tumours
Jaundice Rare; tumour in the head of the pancreas pressing on the bile duct
Pancreatitis Rare

When to seek medical advice

See a doctor if you have ongoing abdominal pain, a lump in the abdomen or early fullness.

Seek urgent help for sudden severe abdominal pain, especially after an injury, or if you become pale, dizzy or faint.

6. Diagnosis

Test Purpose
CT of the abdomen Shows the tumour, nearby blood vessels and liver
MRI Shows bleeding and the mix of solid and cystic areas
Endoscopic ultrasound and biopsy Can confirm the diagnosis before surgery in adults
Blood tests Usually normal; tumour markers such as CA 19-9 and CEA are typically not raised
Pathology after surgery Confirms the diagnosis and checks margins

In children and teenagers, specialist teams often avoid a needle biopsy when scans strongly suggest SPN, because of a small risk of tumour rupture or spread along the needle track. The tumour is then removed whole and examined afterwards.

Conditions that can look similar

Condition How it differs
Pancreatic neuroendocrine tumour Chromogranin- and synaptophysin-positive; may produce hormones
Mucinous cystic neoplasm Cyst with mucus and ovarian-type tissue; middle-aged women
Pseudocyst Fluid collection after pancreatitis; no solid tissue
Pancreatoblastoma Young children; squamoid nests; raised AFP in many
Acinar cell carcinoma Older adults; acinar markers

7. Treatment

The treatment for SPN is surgical removal of the tumour with clear margins. This cures the great majority of people (Law et al., 2014; Lubezky et al., 2017).

Types of surgery

Tumour position Operation
Head of the pancreas Pancreaticoduodenectomy (Whipple operation)
Neck or middle Central pancreatectomy, which spares more of the pancreas
Body or tail Distal pancreatectomy, ideally keeping the spleen
Small tumours at the surface Enucleation, removing the tumour alone, in selected cases

Surgery is often done by keyhole (laparoscopic) or robotic methods in specialist centres. Extensive removal of lymph nodes is not usually needed, because SPN rarely spreads to them.

Spread or recurrence

Situation Treatment
Spread to the liver at diagnosis Removal of the pancreatic tumour and the liver lesions when possible
Local recurrence Further surgery
Disease that cannot be removed Chemotherapy, radiotherapy, ablation or embolisation; results are limited, but disease often grows slowly

Recovery after surgery

Stage What to expect
Hospital stay Usually about one week, depending on the operation
Eating Gradual return to normal diet
Pancreatic leak The most common complication; usually settles with a drain
Back to school or work Often within 4-8 weeks

SPN in children and teenagers

SPN is the most common pancreatic tumour in adolescents, and it is usually discovered in the second decade of life, mostly in girls. European paediatric experts have published joint recommendations for its diagnosis, treatment and follow-up, stressing that the key to cure is complete removal with microscopically clear margins (Irtan et al., 2026).

Young people are treated by paediatric surgeons with experience in pancreatic surgery, often working with adult pancreatic surgeons. Operations that preserve as much pancreas as possible, and the spleen where safe, are preferred, because the patient has a long life ahead.

A common way for SPN to be found in children is after a minor injury to the abdomen, for example from a bicycle handlebar or during sport. The injury may cause bleeding into the tumour and sudden pain, leading to a scan.

Pregnancy and SPN

Because SPN affects young women, it is sometimes found during pregnancy. The tumour may grow during pregnancy, possibly because of hormonal changes. Surgery is usually planned for the second trimester or after delivery, depending on the size of the tumour and the symptoms. Treatment is planned by a team including surgeons, obstetricians and anaesthetists.

How surgery affects the pancreas

Operation Effect on digestion and blood sugar
Enucleation or central pancreatectomy Most pancreatic tissue is kept; digestion and blood sugar usually stay normal
Distal pancreatectomy Usually little effect; a small risk of diabetes later in life
Whipple operation Some people need enzyme capsules with meals; diet usually returns to normal over months

Your team will choose the operation that removes the tumour safely while keeping as much healthy pancreas as possible. Before surgery, ask what to expect for your digestion and energy levels in the first months.

8. Outlook (prognosis)

The outlook is excellent. More than 95% of people are cured by surgery (Law et al., 2014).

Situation Outlook
Tumour completely removed Cure in the vast majority
Recurrence About 4-5% in large reviews, higher in some series; often years later, so long follow-up is needed
Spread to the liver Still often compatible with long survival, especially after surgery (Hao et al., 2018)
Tumour that cannot be removed Poorer outlook, but many still live for years

Features that may suggest a higher risk of recurrence include large size, growth into nearby organs or blood vessels, spread to the liver, and certain microscopic features such as tumour growing into the walls of larger blood vessels (Estrella et al., 2014).

9. Follow-up

Because recurrences can appear many years later, follow-up usually lasts at least 5-10 years.

Follow-up Purpose
Ultrasound, CT or MRI scans Check for recurrence, at increasing intervals
Blood sugar tests Rarely, diabetes after larger pancreatic operations
Digestion checks Enzyme supplements if needed
Vaccinations If the spleen was removed

10. Living with SPN

  • Recover gradually; avoid heavy lifting for several weeks after surgery
  • Eat small, frequent meals while your digestion settles
  • Ask about enzyme supplements if you have fatty, pale stools or weight loss
  • Keep follow-up appointments, even if you feel well
  • Seek support; finding a “tumour” at a young age can be frightening, even with an excellent outlook
  • Ask about pregnancy planning; most people can have children normally after recovery
  • Return to exercise gradually, starting with walking and building up over several weeks
  • Keep a copy of your operation and pathology reports, which will be useful if you move or change doctors during the long follow-up period

11. Frequently asked questions

Question Answer
Is SPN pancreatic cancer? It is a low-grade malignant tumour, but it is very different from the common type of pancreatic cancer and is usually cured
Will I need chemotherapy? Usually not; surgery alone is the standard treatment
Is it inherited? Usually not
Why is it more common in young women? This is not known; hormones may play a role
Can men get SPN? Yes, but much less often
Can it come back? Rarely, sometimes after many years
Should my family be screened? No; SPN is not usually inherited, so relatives do not need tests
Can I play sport after surgery? Yes, once the wound has healed and your surgeon agrees, usually after a few months
Will I be able to eat normally? Most people return to a normal diet after recovery

12. Questions to ask your care team

  • Where in the pancreas is the tumour, and which operation do you recommend?
  • Can the operation be done by keyhole or robotic surgery?
  • Can my spleen be kept?
  • Were the margins clear?
  • Did the tumour show any high-risk features?
  • How long will follow-up last, and which scans will I have?

Resources

  1. Abraham, S.C. et al. (2002) ‘Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations’, American Journal of Pathology, 160(4), pp. 1361-1369.
  2. Estrella, J.S. et al. (2014) ‘Solid pseudopapillary neoplasm of the pancreas: clinicopathologic and survival analyses of 64 cases from a single institution’, American Journal of Surgical Pathology, 38(2), pp. 147-157.
  3. Hao, E.I.U. et al. (2018) ‘Aggressiveness of solid pseudopapillary neoplasm of the pancreas: a literature review and meta-analysis’, Medicine, 97(49), e13147.
  4. Irtan, S. et al. (2026) ‘Solid pseudopapillary neoplasm of the pancreas in children and adolescents: expert recommendations’, Pediatric Blood and Cancer, e70546. doi:10.1002/1545-5017.70546.
  5. Law, J.K. et al. (2014) ‘A systematic review of solid-pseudopapillary neoplasms: are these rare lesions?’, Pancreas, 43(3), pp. 331-337.
  6. Lubezky, N. et al. (2017) ‘Solid pseudopapillary neoplasm of the pancreas: management and long-term outcome’, European Journal of Surgical Oncology, 43(6), pp. 1056-1060.
  7. Papavramidis, T. and Papavramidis, S. (2005) ‘Solid pseudopapillary tumors of the pancreas: review of 718 patients reported in English literature’, Journal of the American College of Surgeons, 200(6), pp. 965-972.
  8. National Cancer Institute (2026) Childhood Pancreatic Cancer Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/pancreatic/hp/child-pancreatic-treatment-pdq (Accessed: October 2026).
  9. WHO Classification of Tumours Editorial Board (2019) Digestive system tumours. 5th edn. Lyon: International Agency for Research on Cancer.

Prepared by the editorial team, October 2026.